Literature DB >> 3305583

Expression of class II major histocompatibility complex antigens on alveolar epithelium in interstitial lung disease: relevance to pathogenesis of idiopathic pulmonary fibrosis.

C G Kallenberg, B M Schilizzi, F Beaumont, L De Leij, S Poppema, T H The.   

Abstract

To determine whether expression of class II major histocompatibility complex antigens on alveolar epithelium is relevant to the pathogenesis of idiopathic pulmonary fibrosis (IPF) lung biopsy specimens were investigated from nine patients with IPF with or without connective tissue disease, four patients with sarcoidosis, eight patients with lung disease of presumably infectious origin, and five controls. The alveolar epithelium stained strongly with anti-Ia (HLA-DR) or Leu 10 (HLA-DS) monoclonal antibodies, in eight of nine biopsy specimens from patients with IPF, in three of four biopsy specimens from patients with sarcoidosis, in all six biopsy specimens from patients with presumably viral, mycobacterial, or pneumocystic lung disease, but not in control lung tissue, nor in two biopsy specimens from patients with bacterial pneumonia. Mononuclear cell infiltrates consisted of T4 positive (helper/inducer) lymphocytes, predominantly present in a nodular arrangement in the interstitium, and T8 positive (cytotoxic/suppressor) cells, distributed equally in the interstitium and subepithelially or intraepithelially. T8 cells outnumbered T4 cells in six of nine biopsy specimens from patients with IPF, but in none of the biopsy specimens from patients with sarcoidosis or interstitial lung disease of infectious origin. Although the expression of class II antigens on the alveolar epithelium which is infiltrated by T8 cells in IPF is consistent with local presentation of autoantigens and an ensuing local immune response, class II expression is also present in interstitial lung disease of sarcoidosis and microbial infections: its role in the pathogenesis of IPF must therefore remain speculative.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3305583      PMCID: PMC1141088          DOI: 10.1136/jcp.40.7.725

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  19 in total

1.  Expression of class II MHC antigens on alveolar epithelium in fibrosing alveolitis.

Authors:  C G Kallenberg; B M Schilizzi; F Beaumont; S Poppema; L De Leij; T H The
Journal:  Clin Exp Immunol       Date:  1987-01       Impact factor: 4.330

2.  Immunohistological analysis of lung tissue from patients with cryptogenic fibrosing alveolitis suggesting local expression of immune hypersensitivity.

Authors:  D A Campbell; L W Poulter; G Janossy; R M du Bois
Journal:  Thorax       Date:  1985-06       Impact factor: 9.139

3.  Characterization of a human B lymphocyte-specific antigen.

Authors:  P Stashenko; L M Nadler; R Hardy; S F Schlossman
Journal:  J Immunol       Date:  1980-10       Impact factor: 5.422

Review 4.  Interstitial lung diseases of unknown cause. Disorders characterized by chronic inflammation of the lower respiratory tract (first of two parts).

Authors:  R G Crystal; P B Bitterman; S I Rennard; A J Hance; B A Keogh
Journal:  N Engl J Med       Date:  1984-01-19       Impact factor: 91.245

5.  Definition and clinical relevance of antibodies to nuclear ribonucleoprotein and other nuclear antigens in patients with cryptogenic fibrosing alveolitis.

Authors:  J R Chapman; P J Charles; P J Venables; P J Thompson; P L Haslam; R N Maini; M E Turner Warwick
Journal:  Am Rev Respir Dis       Date:  1984-09

6.  Antibodies in some chronic fibrosing lung diseases. I. Non organ-specific autoantibodies.

Authors:  M Turner-Warwick; P Haslam
Journal:  Clin Allergy       Date:  1971-03

7.  Interstitial lung disease in primary biliary cirrhosis.

Authors:  E Weissman; N H Becker
Journal:  Am J Med Sci       Date:  1983 May-Jun       Impact factor: 2.378

8.  Controlled trial of faecal occult blood testing in the detection of colorectal cancer.

Authors:  J D Hardcastle; P A Farrands; T W Balfour; J Chamberlain; S S Amar; M G Sheldon
Journal:  Lancet       Date:  1983-07-02       Impact factor: 79.321

9.  Interferon-gamma induces HLA-DR expression by thyroid epithelium.

Authors:  I Todd; R Pujol-Borrell; L J Hammond; G F Bottazzo; M Feldmann
Journal:  Clin Exp Immunol       Date:  1985-08       Impact factor: 4.330

10.  Pulmonary sarcoidosis: a disorder mediated by excess helper T-lymphocyte activity at sites of disease activity.

Authors:  G W Hunninghake; R G Crystal
Journal:  N Engl J Med       Date:  1981-08-20       Impact factor: 91.245

View more
  10 in total

1.  The critical early proinflammatory events associated with idiopathic pneumonia syndrome in irradiated murine allogeneic recipients are due to donor T cell infusion and potentiated by cyclophosphamide.

Authors:  A Panoskaltsis-Mortari; P A Taylor; T M Yaeger; O D Wangensteen; P B Bitterman; D H Ingbar; D A Vallera; B R Blazar
Journal:  J Clin Invest       Date:  1997-09-01       Impact factor: 14.808

2.  Pulmonary gamma interferon production in patients with fibrosing alveolitis.

Authors:  B W Robinson; A H Rose
Journal:  Thorax       Date:  1990-02       Impact factor: 9.139

3.  Skeletal muscle expression of class II histocompatibility antigens (HLA-DR) in polymyositis and other muscle disorders with an inflammatory infiltrate.

Authors:  J A Zuk; A Fletcher
Journal:  J Clin Pathol       Date:  1988-04       Impact factor: 3.411

Review 4.  Idiopathic interstitial pneumonias: progress in classification, diagnosis, pathogenesis and management.

Authors:  Talmadge E King
Journal:  Trans Am Clin Climatol Assoc       Date:  2004

5.  Major histocompatibility complex and alveolar epithelial apoptosis in idiopathic pulmonary fibrosis.

Authors:  Ramcés Falfán-Valencia; Angel Camarena; Armida Juárez; Carina Becerril; Martha Montaño; José Cisneros; Felipe Mendoza; Julio Granados; Annie Pardo; Moisés Selman
Journal:  Hum Genet       Date:  2005-11-15       Impact factor: 4.132

6.  Similar frequency of autoantibodies against pneumocytes type II and Clara cells in patients with interstitial lung diseases and healthy persons.

Authors:  R Erlinger; G Rauh; J Behr; U Schumacher; U Welsch; N Zöllner
Journal:  Klin Wochenschr       Date:  1991-05-03

7.  Increased levels of endothelin-1 and differential endothelin type A and B receptor expression in scleroderma-associated fibrotic lung disease.

Authors:  D J Abraham; R Vancheeswaran; M R Dashwood; V S Rajkumar; P Pantelides; S W Xu; R M du Bois; C M Black
Journal:  Am J Pathol       Date:  1997-09       Impact factor: 4.307

8.  Phenotypic characterization of alveolar capillary endothelial cells, alveolar epithelial cells and alveolar macrophages in patients with pulmonary fibrosis, with special reference to MHC class II antigens.

Authors:  T Komatsu; M Yamamoto; K Shimokata; H Nagura
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1989

9.  Postoperative outcomes of lung transplant recipients with preformed donor-specific antibodies.

Authors:  Hidenao Kayawake; Toyofumi F Chen-Yoshikawa; Fumiaki Gochi; Satona Tanaka; Kimiko Yurugi; Rie Hishida; Yojiro Yutaka; Yoshito Yamada; Akihiro Ohsumi; Masatsugu Hamaji; Daisuke Nakajima; Hiroshi Date
Journal:  Interact Cardiovasc Thorac Surg       Date:  2021-04-19

10.  Imbalance of pro- and anti-inflammatory cytokines in pulmonary sarcoidosis.

Authors:  J Müller-Quernheim
Journal:  Mediators Inflamm       Date:  1996       Impact factor: 4.711

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.